Virpax Pharmaceuticals, Inc.
Virpax Pharmaceuticals, Inc. (VRPX) is a publicly traded company in the Unknown sector. Across all available filings, 5 corporate insiders have executed 7 transactions totaling $253.5K, demonstrating a bullish sentiment with $253.5K in net insider flow. The most recent transaction on May 24, 2022 involved a purchase of 4,500 shares valued at $5.8K.
VRPX Insider Activity Summary
Who Is Buying VRPX Stock?
No significant insider buying has been recorded for VRPX in the recent period.
Who Is Selling VRPX Stock?
No significant insider selling has been recorded for VRPX in the recent period.
Is Virpax Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for VRPX is bullish with an Insider Alignment Score of 100/100 and a net flow of $253.5K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
VRPX Frequently Asked Questions
Understanding VRPX Insider Activity
Insider trading at Virpax Pharmaceuticals, Inc. (VRPX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 5 insiders are actively trading VRPX stock, having executed 7 transactions in the past 90 days. The most active insider is Anthony P. Mack (Executive), who has made 2 transactions totaling $201.8K.
Related Tools
Track Virpax Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at VRPX file new Form 4 transactions